THE CONAFAY GROUP, LLC

Lobbying for REVAGENIX, INC. · Biopharmaceutical company creating anti-infective medicines.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · California · House · Senate · $50,000.00 income · posted Apr 20, 2026

Lobbying activity 2

Medical/Disease Research/Clinical Labs

Opportunities to promote antimicrobial drug development.

Health Issues

Opportunities to promote antimicrobial drug development.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.